Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: Copper Supplementation in Cirrhosis [NA]

View source ↗

Summary

An ongoing University of Washington clinical trial is evaluating copper supplementation in patients with liver disease, including cirrhosis and chronic liver di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Copper supplement (Copper)

Snippet

Sponsor: University of Washington | Conditions: Cirrhosis, Chronic Liver Disease | NA | Status: RECRUITING